pevifoscorvir
Generic: ALG-000184·Code: ALG-000184
pevifoscorvir: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Aligos Therapeutics, Inc. (ALGS) | Phase 2 |
Clinical Trials (1)
A Phase 1 Non-Randomized, Open-Label, Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function
Frequently asked questions
Who is developing pevifoscorvir?
pevifoscorvir is being developed by Aligos Therapeutics, Inc..
How many clinical trials involve pevifoscorvir?
BioSniper tracks 1 clinical trial involving pevifoscorvir.
Get deeper analysis on pevifoscorvir
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis